The role of β-amyloid peptide in neurodegenerative diseases
Authors:
- A.V. MaltsevA.V. Maltsev
- S. BystryakSBS. Bystryak
- O.V. GalzitskayaOGO.V. Galzitskaya
- 1 September 2011
- journal article
- review article
- Published by Elsevier in Ageing Research Reviews
- Vol. 10 (4) , 440-452
Abstract
No abstract availableKeywords
This publication has 129 references indexed in Scilit:
- Presenilins are essential for regulating neurotransmitter releaseNature, 2009
- β-Sheet core of human prion protein amyloid fibrils as determined by hydrogen/deuterium exchangeProceedings of the National Academy of Sciences, 2007
- Monomer adds to preformed structured oligomers of Aβ-peptides by a two-stage dock–lock mechanismProceedings of the National Academy of Sciences, 2007
- Experimental Constraints on Quaternary Structure in Alzheimer's β-Amyloid FibrilsBiochemistry, 2005
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- 3D structure of Alzheimer's amyloid-β(1–42) fibrilsProceedings of the National Academy of Sciences, 2005
- Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteinsNature Biotechnology, 2004
- Pathways towards and away from Alzheimer's diseaseNature, 2004
- Rationalization of the effects of mutations on peptide andprotein aggregation ratesNature, 2003
- Regulated Intramembrane ProteolysisCell, 2000